So if it is time to earn 7 credits towards your New York State license, OpticalCEUs has what you want and need! Pick up the latest ideas in the field - from lens technology to reduce blue light exposure to rigid contact lens fitting. Earn your ABO/NCLE credits with 7 courses at the CELEBRITY BALLROOM, FOX TOWER, Foxwoods Resort and Casino on Sunday, October 22. So register now online.
Monday, September 18, 2017
OpticalCEU's Seminar Now Approved for New York State Credit!
In association with the Opticians Alliance of New York, OpticalCEUs is offering credits to a New York opticians license (ID 071317-071220.017). OpticalCEUs welcomes New York Opticians for a day of learning and fun at Foxwoods. You can register here.
So if it is time to earn 7 credits towards your New York State license, OpticalCEUs has what you want and need! Pick up the latest ideas in the field - from lens technology to reduce blue light exposure to rigid contact lens fitting. Earn your ABO/NCLE credits with 7 courses at the CELEBRITY BALLROOM, FOX TOWER, Foxwoods Resort and Casino on Sunday, October 22. So register now online.
So if it is time to earn 7 credits towards your New York State license, OpticalCEUs has what you want and need! Pick up the latest ideas in the field - from lens technology to reduce blue light exposure to rigid contact lens fitting. Earn your ABO/NCLE credits with 7 courses at the CELEBRITY BALLROOM, FOX TOWER, Foxwoods Resort and Casino on Sunday, October 22. So register now online.
Wednesday, September 13, 2017
Linda Conlin Named Managing Editor of Pro to Pro for 20/20 Magazine
As the
new Managing Editor of Pro to Pro for 20/20 Magazine,
Linda Conlin invites you to check out the latest issue at
https://www.2020mag.com/. You can contact her (lindaconlin@opticalceu.com) to sign up for Pro to Pro "Email Blasts".
Register Now for OpticalCEU's Fall Continuing Education Seminar for Opticians
Is
it time to renew your state license and ABO/NCLE certification?
Why not do it with the best value in continuing
education? Do
you need a full-day, 7-credit program?
Either way, F.E. Enterprises’ OpticalCEUs has what you
want and need! So
register now online.
Pick
up the latest ideas in the field - from lens technology to
reduce blue light exposure to rigid contact lens fitting.
Earn your ABO/NCLE credits with 7 courses at the
CELEBRITY BALLROOM, FOX TOWER, Foxwoods Resort and
Casino on Sunday,
October 22.
They’ll help you:
·
Explore options in new blue filter lens technology
·
Learn about medications that affect vision
·
Provide top-notch patient care with rigid contact
lens fitting
·
Understand and experience optical phenomena
Register now! Earn
accreditation! Have some
Foxwoods fun!
P.S.
As always, conference attendees can enjoy a delicious hot
buffet lunch compliments of OpticalCEUs.
Our Lecturers
Accredited lecturers
Linda Conlin, Deborah Kotob of
Vision-Ease and
Joe Forte will
present seven courses enabling you to earn three ABO and four
NCLE credits.
For over 15
years
Linda, the new Managing
Editor for 20/20
Magazine’s Pro to Pro,
has
provided
continuing
education and training
for
opticians
at
the
state
and
national
levels.
She
is ABO and NCLE
certified,
licensed in CT, MA and RI, and has written
for 20/20 and
EyeWitness
magazines.
She founded OpticalCEUs and launched OpticalCEU.com and
Optical News from
OpticalCEUs news blog for opticians.
Deborah,
the
ECP Education Facilitator
for
Vision-Ease, creates
and
presents
ABO,
NCLE and JCAHPO
seminars
related
to optics and
best
practices. A
Massachusetts-licensed optician, she
has
owned
two
optical
businesses
and
was
a
sales
representative
for
MODO
and
Luxottica.
Deborah has achieved
ABOM
and
NCLE certifications.
Joe,
the director of contact lens services for Greenwich
Ophthalmology Associates, lectured at CUNY Tech, Vision Expo and
Optifair. He received his Master in Contact Lens Technology
(NCLEM), is certified as an Advanced Level speaker, and was
program director of the Interboro Institute College of
Opticianry where he taught courses in various areas of contact
lenses and optics. Joe has been a Fellow of the CLSA since 1992.
Directions
FOX
TOWER, FOXWOODS is located at 39 Norwich-Westerly Rd, Ledyard, CT 06339 on Route 2
between I-395 and I-95.
Go to
www.OpticalCEU.com for map and directions.
Valet parking is free.
For accommodations, call Foxwoods at 1-800 PLAY BIG.
Overnight reservations are not associated with the
seminar.
Help OAA Support Texas Opticians
We received the following email from the Opticians Association of America:
We are all aware of the devastating hurricane that wreaked havoc in the State of Texas. The Opticians Association of America is working with the Certified Opticians Association of Texas (COAT) to assist those opticians whose dispensaries and homes were damaged during the historic storm.
COAT is hopeful to raise a minimum of $10,000 in order to help these opticians. Unfortunately, most people in the Houston area do not have flood insurance. OAA is asking that you make a donation through COAT's GoFundMe Page (https://www.gofundme.com/helptexasopticians).
Any size gift is deeply appreciated as we try to assist our fellow opticians recover from the devastating damage caused by the hurricane. Click Here to make your donation today.Thank you for your support and please keep your thoughts and prayers with the people of Texas.
Friday, August 18, 2017
Kala Looking to Fund Expansion into Drug Delivery System Using Mucous Penetrating Particles
"Drugs that must pass through protective layers of mucus to deliver treatment to organs of the body are often not very effective, because the mucus—a sticky, meshlike material—prevents the drug from ever reaching its intended target," according to a Johns Hopkins University Ventures newsletter.
"But hope is on the horizon in the form of a novel drug delivery system developed over the past 15 years by a research team led by Justin Hanes, director of the Center for Nanomedicine at the Wilmer Eye Institute at Johns Hopkins.
"Hanes’s system packages drugs into nanoparticles small enough to penetrate a mucus layer through tiny openings in the sticky mesh, and it gives those nanoparticles a minimally adhesive coating that enables them to slide through the mesh without getting stuck to it. Kala Pharmaceuticals, a startup co-founded by Hanes, is developing these coated nanoparticles."
In another release about the development: "Biopharmaceutical firm Kala Pharmaceuticals is focused on developing treatments for eye conditions and diseases using its proprietary mucous penetrating particles technologies," according to Don Dion, of SA Stock Market News. "The company completed very promising Phase III clinical trials for delivering drugs to relieve pain and inflammation following ocular surgery. So far, it has applied MPP technology in two product candidates (KPI-121 1.0% and KPI-121 0.25%), both of which are in Phase III clinical development. It anticipates submitting new drug applications for KPI-121 1.0% and KPI-121 0.25% by the end of 2017 and the first half of 2018, respectively. Kala Pharmaceuticals was founded in 2009 and is based in Waltham, Mass." For more information go to these sites: SA Stock Market News and Johns Hopkins University Ventures Program.
"But hope is on the horizon in the form of a novel drug delivery system developed over the past 15 years by a research team led by Justin Hanes, director of the Center for Nanomedicine at the Wilmer Eye Institute at Johns Hopkins.
"Hanes’s system packages drugs into nanoparticles small enough to penetrate a mucus layer through tiny openings in the sticky mesh, and it gives those nanoparticles a minimally adhesive coating that enables them to slide through the mesh without getting stuck to it. Kala Pharmaceuticals, a startup co-founded by Hanes, is developing these coated nanoparticles."
In another release about the development: "Biopharmaceutical firm Kala Pharmaceuticals is focused on developing treatments for eye conditions and diseases using its proprietary mucous penetrating particles technologies," according to Don Dion, of SA Stock Market News. "The company completed very promising Phase III clinical trials for delivering drugs to relieve pain and inflammation following ocular surgery. So far, it has applied MPP technology in two product candidates (KPI-121 1.0% and KPI-121 0.25%), both of which are in Phase III clinical development. It anticipates submitting new drug applications for KPI-121 1.0% and KPI-121 0.25% by the end of 2017 and the first half of 2018, respectively. Kala Pharmaceuticals was founded in 2009 and is based in Waltham, Mass." For more information go to these sites: SA Stock Market News and Johns Hopkins University Ventures Program.
Friday, May 5, 2017
OpticalCEUs Spring Seminar, A Success!
- Advise your patients about the effects of blue light exposurez
- Review spectacle lens options and considerations for the correction of Ametropia and Presbyopia
- Provide top-notch patient care with new technology for specialty contact lens fitting
- Expand your knowledge of contact lens materials, treatments and their applications.
Subscribe to:
Posts (Atom)